Research Projects Funded
Faster, more transparent funding
VitaDAO's Longevity Dealflow team works with you to ensure a swift and uncomplicated funding application process. A dedicated community member becomes your single point of contact to guide you throughout the application journey, and applications receive an answer within 2 weeks of submission.
We back research that others don’t
We believe in innovative, groundbreaking aging research. VitaDAO is fully independent and self-governed, which means we back moonshots: highly novel projects that present higher risk, but have the potential to make revolutionary contributions to science.
Support every step of the way
Our team works with you to incubate your research from the lab, help with your IP strategy, plan for commercialisation and get your project ready for building. The VitaDAO model is designed to ensure funded projects enjoy the best chance at successful commercialisation that our network can provide, giving you more time to focus on your work in the lab.
VitaDAO is a mission-aligned community of longevity enthusiasts and professional contributors. A large and diverse community means you benefit from access to funders, communicators, technologists, and a robust network of leading researchers, all working to advance longevity science in an open and collaborative way.
The VitaDAO funding process
VitaDAO and the Gorbunova Lab are launching Matrix Bio, a cutting-edge research venture leveraging the anti-cancer and pro-longevity effects of high molecular weight hyaluronic acid from naked mole rat to human.
What if therapeutics to slow down the aging process and prevent age-related disease already existed? The Scheibye-Knudsen Lab will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan.
Turn Bio develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. They are reprogramming the epigenome – a network of chemical compounds and proteins controlling cell functions to restore capabilities that are lost with age.
ARTAN Bio - Mutation-Specific Codon Suppression for Aging and Longevity
ARTAN is a biotechnology company developing first-in-class interventions to tackle the most frequent nonsense mutations implicated in a wide range of age-related diseases and cancers. These nonsense mutations induce premature stops of protein translation when occurring in coding regions.
Are you working on the next longevity science breakthrough?
The Longevity Prize
A series of prizes awarding outstanding proces in longevity research. The initiative aims to accelerate progress in the rejuvenation biotechnology field and encourage innovation. The Longevity Prize is crowdsourced and curated by leading industry experts - presented in partnership with Foresight Institute, Methuselah Foundation and Lifespan.io.
The Longevity Fellowship
The Longevity Fellowship provides micro-grants of up to $2,000 USD to passionate individuals in the field of longevity science. The program offers a unique opportunity for scientists, students, and longevity enthusiasts to delve deeper into their research interests, attend conferences, and join programs such as the Longevity Biotech Fellowship.